Dr. Thomas R. McMinn Jr., MD

Dr. McMinn practices at St. David's Medical Center in Austin, Texas, part of HCA Healthcare.

Dr. McMinn's NPI, 1316947344, was assigned on August 1, 2005. Dr. McMinn graduated from WashU Medicine in 1990. Dr. McMinn holds Texas license K6145.

Dr. McMinn's primary practice is St. David's Medical Center, at 919 E 32nd St, Austin, TX 78705 in Travis County. The practice phone is (512) 476-7111.

Dr. McMinn's primary practice is St. David's Medical Center in Austin, Texas, part of HCA Healthcare. Dr. McMinn is also affiliated with St. David's South Austin Medical Center. The medical group on file is Austin Heart. Dmand AI also links Dr. McMinn to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McMinn practices, 4 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. McMinn's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. McMinn is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. McMinn's licenses on file in 3 states: Texas, California and Arizona.

Dmand AI lists angioplasty, cardiac catheterization and pacemaker or defibrillator implantation among the conditions Dr. McMinn treats.

CMS data shows 2,128 Medicare services from Dr. McMinn across 26 procedure codes in 2024, for 868 Medicare patients. Medicare paid $133,075 for them.

CMS counts 868 Medicare patients who saw Dr. McMinn in 2024. The largest group is 75 to 84, with 401 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. McMinn's median patient age at 76, with 37% women.

In 2024, Dr. McMinn wrote 3,413 Medicare Part D claims for 519 patients. 89% of them were for generic drugs. CMS names the drug for 3,208 of them, across 40 drugs with 11 or more claims each, at $365,132 in total drug cost. In 2023, CMS named 3,342 claims across 42 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. McMinn for performance year 2024, reported individually. CMS counts 15 procedures of coronary angioplasty and stenting by Dr. McMinn, more than 40% of the clinicians it reports for that procedure.

Dmand AI links 6 papers to Dr. McMinn, published from 2022 to 2024. 2022 was the busiest year, with 2. The most frequent topics are Heart Failure, Stroke Volume and Ventricular Function, Left. Dr. McMinn's most frequent co-authors are Jeremiah Peter Depta, MD, Brett Ashley Bennett, MD and William Steven Carroll, MD.

CMS Open Payments shows 400 general payments to Dr. McMinn from 33 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 63% of the total. Abbott Laboratories paid the most, $38,151.

Dmand AI lists 1 award for Dr. McMinn.

Dr. McMinn graduated from WashU Medicine in 1990. Dr. McMinn is a member of ACC.

Dr. McMinn is in network with 21 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.